| Jul 31 |
Alcyone Therapeutics Announces Continued Enrollment Approval from FDA of the PIERRE Pivotal IDE Clinical Study of the ThecaFlex DRx™ System for Administration of nusinersen
|
| Jul 30 |
Rigel Pharmaceuticals (RIGL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
| Jul 25 |
Ionis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: Should You Buy?
|
| Jul 24 |
Leerink upgrades Ionis to outperform, cites Angelman drug
|
| Jul 23 |
Ionis (IONS) Up 6% on Detailed Data From Angelman Drug Study
|
| Jul 23 |
Ionis Pharmaceuticals reports data from Phase I/II trial of Angelman syndrome drug
|
| Jul 22 |
Ionis Pharmaceuticals Surges Into Buy Zone As It, Possibly, Proves Biogen Wrong
|
| Jul 22 |
Ionis Pharmaceuticals, Inc. (IONS) HALOS Study of ION582 in Angelman Syndrome - (Transcript)
|
| Jul 22 |
Ionis reports positive Phase 1/2 data for Angelman therapy
|
| Jul 22 |
Ionis plots next steps for Angelman drug Biogen passed on
|
